Trademark: 88377509
Word
JALDURZO
Status
Registered
Status Code
700
Status Date
Tuesday, September 29, 2020
Serial Number
88377509
Registration Number
6161316
Registration Date
Tuesday, September 29, 2020
Mark Type
4000
Filing Date
Tuesday, April 9, 2019
Published for Opposition
Tuesday, July 14, 2020

Trademark Owner History
MorphoSys AG - Original Registrant

Classifications
5 pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies sold as an ingredient of pharmaceuticals for the treatment of treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis
42 research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies

Trademark Events
Sep 29, 2020
Registered-Principal Register
Jul 14, 2020
Official Gazette Publication Confirmation E-Mailed
Jul 14, 2020
Published For Opposition
Jun 24, 2020
Notification Of Notice Of Publication E-Mailed
Jun 8, 2020
Approved For Pub - Principal Register
Jun 8, 2020
Examiner's Amendment Entered
Jun 8, 2020
Notification Of Examiners Amendment E-Mailed
Jun 8, 2020
Examiners Amendment E-Mailed
Jun 8, 2020
Examiners Amendment -Written
May 29, 2020
Teas/Email Correspondence Entered
May 28, 2020
Correspondence Received In Law Office
May 28, 2020
Teas Request For Reconsideration Received
Dec 4, 2019
Notification Of Final Refusal Emailed
Dec 4, 2019
Final Refusal E-Mailed
Dec 4, 2019
Final Refusal Written
Dec 2, 2019
Teas/Email Correspondence Entered
Dec 1, 2019
Correspondence Received In Law Office
Dec 1, 2019
Teas Response To Office Action Received
Jun 19, 2019
Notification Of Non-Final Action E-Mailed
Jun 19, 2019
Non-Final Action E-Mailed
Jun 19, 2019
Non-Final Action Written
Jun 19, 2019
Assigned To Examiner
May 7, 2019
Applicant Amendment Prior To Examination - Entered
May 6, 2019
Assigned To Lie
Apr 28, 2019
Teas Voluntary Amendment Received
Apr 26, 2019
New Application Office Supplied Data Entered In Tram
Apr 12, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24